ArticleFrontiers in bioinformatics2025
Neurogenic locus notch homolog protein 1 (NOTCH 1) SNP informatics coupled with intrinsically disordered regions and post-translational modifications reveals the complex structural crosstalk of Lung Adenocarcinoma (LUAD).
Article in Frontiers in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).Frontiers in molecular neuroscience · 2026Article
- Computational screening of oncogenic genetic variations in tumor suppressor proteins driving gastric cancer pathogenesis.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung adenocarcinoma (LUAD) is the predominant histological subtype of lung cancer, representing a major contributor to cancer mortality rate marked by a high frequency of mutations and intricate interactions between multiple signalling pathways. Objective: Here we explore the role of NOTCH1 associated Single nucleotide polymorphisms (SNPs) IDR and PTM in LUAD progression. Although the NOTCH1 expression is downregulated, it has been validated as an important prognostic marker because of its complex biological roles under specific conditions. Methods: With the aid of In silico tools we predicted and identified the deleterious SNPs. The Molecular Docking and dynamics simulations (MDS) were conducted to characterize these mutations. Results: A total of 43 deleterious SNPs were found in the sequential SNP analysis with 13 SNPs resulted deleterious and damaging effects. The stabilizing SNPs such as S1464I, A1705V and T1602I are found within the conserved and functional domains of NOTCH1. In addition, 1660-2555 sequence region of the PEST domain was recognized as an Intrinsically Disordered Region (IDR) with a score of above 0.5. Moreover, the presence of the two phosphodegrons (SCF_FBW7_1 at 2129-2136 and SCF_FBW7_2 at 2508-2515) along with the Post Translational Modification (PTM) such as o-linked glycosylation and Phosphothreonine within the IDR region, PEST and conserved domains suggest functional significance in LUAD progression. Conclusion: In conclusion our research highlights the potential regulatory role of identified SNPs, PTMs, and the functional domains of Notch1, particularly the PEST domain and IDR, in pathophysiology of LUAD particularly through the crosstalk of the EMT signalling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.